NASDAQ: DHC | Real Estate / REITs / USA |
2.25 | +0.0600 | +2.74% | Vol 1.01M | 1Y Perf 76.61% |
Sep 22nd, 2023 16:00 DELAYED |
BID | 2.15 | ASK | 2.35 | ||
Open | 2.19 | Previous Close | 2.19 | ||
Pre-Market | - | After-Market | 2.13 | ||
- - | -0.12 -5.33% |
Target Price | 3.17 | Analyst Rating | Moderate Buy 2.50 | |
Potential % | 40.89 | Finscreener Ranking | ★★★+ 51.60 | |
Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★★+ 53.26 | |
Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★★+ 54.03 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | ★★ 39.51 | |
Price Range Ratio 52W % | 60.97 | Earnings Rating | — | |
Market Cap | 539.52M | Earnings Date | 1st Nov 2023 | |
Alpha | -0.02 | Standard Deviation | 0.22 | |
Beta | 1.89 |
Today's Price Range 2.132.29 | 52W Range 0.61003.30 | 5 Year PE Ratio Range -5.4035.80 |
Summary:
Sell
Technical Indicators: | Sell |
Moving Averages: | Sell |
Performance | |||
---|---|---|---|
1 Week | -2.60% | ||
1 Month | -23.99% | ||
3 Months | 13.64% | ||
6 Months | 70.45% | ||
1 Year | 76.61% | ||
3 Years | -26.87% | ||
5 Years | -85.59% | ||
10 Years | -83.52% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -0.37 | |||
ROE last 12 Months | 16.59 | |||
ROA (5Y Avg) | -0.15 | |||
ROA last 12 Months | 6.32 | |||
ROC (5Y Avg) | 3.69 | |||
ROC last 12 Months | 10.15 | |||
Return on invested Capital Q | -0.96 | |||
Return on invested Capital Y | 6.59 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 1.44K |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.40 | ||||
0.07 | ||||
0.20 | ||||
10.80 | ||||
2.80 | ||||
1.27 | ||||
0.07 | ||||
11.87 | ||||
2.55B | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.90 | ||||
1.10 | ||||
0.47 | ||||
1.13 | ||||
2.90 | ||||
Leverage Ratio | 2.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
14.50 | ||||
49.30 | ||||
68.30 | ||||
25.80 | ||||
5.23 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
946.68M | ||||
3.95 | ||||
9.56 | ||||
6.92 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
5.00 | ||||
0.04 | ||||
-68.90 | ||||
-53.03 | ||||
Payout ratio | 445.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | 0.09 | 0.05 | -44.44 |
Q01 2023 | 0.05 | 0.05 | 0.00 |
Q04 2022 | -0.01 | 0.03 | 400.00 |
Q03 2022 | 0.03 | -0.06 | -300.00 |
Q02 2022 | 0.00 | -0.04 | - |
Q01 2022 | -0.02 | -0.09 | -350.00 |
Q04 2021 | 0.04 | -0.07 | -275.00 |
Q03 2021 | 0.03 | -0.04 | -233.33 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 1st Nov 2023 |
Estimated EPS Next Report | 0.08 |
Estimates Count | 2 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 1.01M |
Shares Outstanding | 239.79K |
Shares Float | 215.89M |
Trades Count | 5.84K |
Dollar Volume | 2.26M |
Avg. Volume | 2.12M |
Avg. Weekly Volume | 2.43M |
Avg. Monthly Volume | 1.95M |
Avg. Quarterly Volume | 1.99M |
Diversified Healthcare Trust (NASDAQ: DHC) stock closed at 2.25 per share at the end of the most recent trading day (a 2.74% change compared to the prior day closing price) with a volume of 1.01M shares and market capitalization of 539.52M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the REITs industry, Real Estate sector and employs 0 people. Diversified Healthcare Trust CEO is .
The one-year performance of Diversified Healthcare Trust stock is 76.61%, while year-to-date (YTD) performance is 247.87%. DHC stock has a five-year performance of -85.59%. Its 52-week range is between 0.61 and 3.3, which gives DHC stock a 52-week price range ratio of 60.97%
Diversified Healthcare Trust currently has a PE ratio of 0.40, a price-to-book (PB) ratio of 0.07, a price-to-sale (PS) ratio of 0.20, a price to cashflow ratio of 10.80, a PEG ratio of -, a ROA of 6.32%, a ROC of 10.15% and a ROE of 16.59%. The company’s profit margin is 5.23%, its EBITDA margin is 68.30%, and its revenue ttm is $946.68 Million , which makes it $3.95 revenue per share.
Of the last four earnings reports from Diversified Healthcare Trust, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.08 for the next earnings report. Diversified Healthcare Trust’s next earnings report date is 01st Nov 2023.
The consensus rating of Wall Street analysts for Diversified Healthcare Trust is Moderate Buy (2.5), with a target price of $3.17, which is +40.89% compared to the current price. The earnings rating for Diversified Healthcare Trust stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Diversified Healthcare Trust has a dividend yield of 5.00% with a dividend per share of $0.04 and a payout ratio of 445.00%.
Diversified Healthcare Trust has a Sell technical analysis rating based on Technical Indicators (ADX : 7.02, ATR14 : 0.19, CCI20 : -87.83, Chaikin Money Flow : -0.35, MACD : -0.11, Money Flow Index : 23.95, ROC : -6.64, RSI : 41.29, STOCH (14,3) : 14.63, STOCH RSI : 0.29, UO : 44.55, Williams %R : -85.37), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Diversified Healthcare Trust in the last 12-months were: PORTNOY ADAM D. (Buy at a value of $42 464 050)
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Strong Buy | Strong Buy |
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: its office portfolio and its senior housing operating portfolio. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.
CEO:
Telephone: +1 617 796-8350
Address: 255 Washington Street, Newton 02458-1634, MA, US
Number of employees: 0
Fri, 01 Sep 2023 20:16 GMT Diversified Healthcare Trust, Office Properties mutually terminate merger
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.